Concomitant Tricuspid Repair in Patients with Degenerative Mitral Regurgitation.
James S GammieMichael W A ChuVolkmar FalkJessica R OverbeyAlan J MoskowitzMarc GillinovMichael J MackPierre VoisineMarkus KraneBabatunde YerokunMichael E BowdishLenard ConradiSteven F BollingMarissa A MillerWendy C Taddei-PetersNeal O JeffriesMichael K ParidesRichard WeiselMariell JessupEric A RoseJohn C MullenSamantha RaymondEllen G MoqueteKaren O'SullivanMary E MarksAlexander IribarneFriedhelm BeyersdorfMichael A BorgerArnar GeirssonEmilia BagiellaJudy HungAnnetine C GelijnsPatrick T O'GaraGorav Ailawadinull nullPublished in: The New England journal of medicine (2021)
Among patients undergoing mitral-valve surgery, those who also received TA had a lower incidence of a primary-end-point event than those who underwent mitral-valve surgery alone at 2 years, a reduction that was driven by less frequent progression to severe tricuspid regurgitation. Tricuspid repair resulted in more frequent permanent pacemaker implantation. Whether reduced progression of tricuspid regurgitation results in long-term clinical benefit can be determined only with longer follow-up. (Funded by the National Heart, Lung, and Blood Institute and the German Center for Cardiovascular Research; ClinicalTrials.gov number, NCT02675244.).